Stish, Brad2010-07-212010-07-212010-07-21https://hdl.handle.net/11299/92202The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.When using beta-blocker for blood pressure in patients with Type II diabetes mellitus, the metabolic effects of Carvedilol are superior to those of Metoprolol. While both drugs appear to have equivalent ability to lower blood pressure, patients taking Carvedilol better HgbA1c levels, improved insulin sensitivity, and lower levels of microalbuminuria.en-USDiabetesHypertensionBeta BlockerCarvedilolMetoprololOther